Up In Smoke: Cannabis and Cardiovascular Health

Speaker | Dr. Deirdre O'Neill [speaker evaluation]

Learning Objectives: Explore the physiological effects of cannabis on cardiovascular health.  Review current evidence regarding the safety of cannabis in cardiovascular diseases.  Understand the potential precautions of cannabis for cardiovascular patients.



A 2019 View on Aspirin

Speaker | Dr. Michelle Graham [speaker evaluation]

Learning Objectives: Review the recent evidence of ASA for primary prevention.  Review the evidence of ASA for secondary prevention in coronary artery disease.  Understand the appropriate indications for when to prescribe and when to deprescribe ASA.



Should We Go with The Flozin

Speaker | Dr. Robert Welsh [speaker evaluation]

Learning Objectives: Review cardiovascular effects of SGLT2 Inhibitors and GLP1 Agonists.  Review cardiovascular effects and role of other diabetic medications.  Understand when to use SGLT2 Inhibitors and GLP1 Agonists in diabetic patients to maximize cardiovascular risk reduction.



My Patient is 1- Year Post-MI:  What Now?

Speaker | Dr. Wayne Tymchak [speaker evaluation]

Learning Objectives: Review evidence for antithrombotic agents 1-year post ACS in patients with and without atrial fibrillation.  Review evidence for other cardiovascular agents (e.g. statins, beta blocker, ace inhibitor) 1-year post ACS.  Determine which of these agents to continue or deprescribe at the 1-year mark based on your patient assessment.





Differential Diagnosis of Dyspnea: How to Approach and Assess a Patient Presenting with SOB

Speaker | Dr. Brian Sonnenberg [speaker evaluation]

Learning Objectives:  Develop a step-by-step approach to assessing a patient presenting with dyspnea.  Understand differential diagnosis of dyspnea.  Review assessment techniques to determine the proper diagnosis.



Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA):  What is it?  How Do We Diagnose it?  How Do We Treat It?

Speaker | Dr. Kevin Bainey [speaker evaluation]

Learning Objectives:  Understand the causes of MINOCA.  Develop an approach to assessing and diagnosing a patient with MINOCA.  Review treatment options for patients with MINOCA.



Sexual Counselling in Cardiac Rehab: Getting Beyond 6 Minutes

Speaker | Dr. Deirdre O'Neill [speaker evaluation]

Learning Objectives: Understand drug interaction between nitroglycerin and PD5 inhibitors (e.g. Viagra, Cialis).  Review the common comorbidities and added challenges of treating cardiac conditions. Review the evidence and role of cardiac medications. Understand how to de-prescribe certain cardiac medications in this population.



Approach to ECG Interpretation

Speaker | Dr. Bradley Brochu [speaker evaluation]

Learning Objectives:  Review basic ECG interpretation skills and develop a systematic approach.  Review key differentiating factors that help determine diagnoses.  Practice example ECG’s using a systematic approach.



PAD: Will COMPASS Guide Us

Speaker | Dr. Sean McMurtry [speaker evaluation]

Learning Objectives:  Understand the clinical implications of PAD and polyvascular disease and review contemporary pharmacologic management with or without coronary disease.



My  Watch Diagnosed Me with Atrial Fibrillation [screening]

Speaker | Dr. Roopinder Sandhu [speaker evaluation]

Learning Objectives:  Novel technology screening AF and (ii) AF and PCI - reviewing trials (PIONEER, REDUAL and AUGUSTUS), and guideline recommendations focusing on acute management of antithrombotic therapy.



Transition Post-Cardiovascular Surgery: It’s Not So Cut and Dry

Speaker | Dr. Wei Wang [speaker evaluation]

Learning Objectives: Understand follow up process post-CV surgery.  Outline physician responsibility for assessing medications post-op.  Differentiate who and when to stop warfarin for post op atrial fibrillation and who titrates heart failure therapies.



PARADIGM Shifts in Heart Failure

Speaker | Dr. Lindsey Carter [speaker evaluation]

Learning Objectives:  Review the role and benefit of current heart failure medications.  Develop an approach to initiating, titrating, and switching heart failure medications.  Understand monitoring parameters that guide optimization of heart failure therapies.